Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 52, Issue 8, Pages 2915-2918Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00461-08
Keywords
-
Categories
Funding
- NICHD NIH HHS [HD051796, R01 HD051796] Funding Source: Medline
Ask authors/readers for more resources
Beta-lactam antibiotics (BLAB) are the first-line agents used against group B streptococci (GBS) infection. A clonal set of four independent, invasive GBS isolates with elevated MICs to BLAs were identified that shared a pbp2x mutation (Q557E) corresponding to a resistance-conferring pneumococcal mutation. BLA sensitivity was restored through allelic replacement or complementation with the wild-type pbp2x.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available